APA (7th ed.) Citation

Z, P., MJ, A., PJ, V., YK, P., SH, H., SW, K., . . . BC, C. (2026). ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib. Cancer discovery, 16(6), 1074. https://doi.org/10.1158/2159-8290.CD-25-0960

Chicago Style (17th ed.) Citation

Z, Piotrowska, et al. "ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib." Cancer Discovery 16, no. 6 (2026): 1074. https://doi.org/10.1158/2159-8290.CD-25-0960.

MLA (9th ed.) Citation

Z, Piotrowska, et al. "ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib." Cancer Discovery, vol. 16, no. 6, 2026, p. 1074, https://doi.org/10.1158/2159-8290.CD-25-0960.